Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 5:29 pm Unchanged |
2025-03-06 | 13D | OptimizeRx Corporation OPRX |
Whetstone Capital Advisors, LLC | 1,508,303 8.200% |
0 (Unchanged) |
Filing History |
| 2025-02-13 10:34 am Sale |
2024-12-31 | 13G | OptimizeRx Corporation OPRX |
SAMJO MANAGEMENT, LLC | 50 0.000% |
-1,044,750 (-100.00%) |
Filing History |
| 2025-02-05 11:41 am Purchase |
2025-02-03 | 13D | OptimizeRx Corporation OPRX |
Whetstone Capital Advisors, LLC | 1,508,303 8.200% |
1,508,303 (New Position) |
Filing History |
| 2025-01-28 12:58 pm Purchase |
2024-12-31 | 13G | OptimizeRx Corporation OPRX |
ROYCE & ASSOCIATES LLC | 1,069,560 5.810% |
1,069,560 (New Position) |
Filing History |
| 2025-01-08 4:37 pm Sale |
2024-12-31 | 13G | OptimizeRx Corporation OPRX |
First Light Asset Management, LLC | 0 0.000% |
-1,829,074 (Position Closed) |
Filing History |
| 2024-12-06 4:26 pm Sale |
2024-11-30 | 13G | OptimizeRx Corporation OPRX |
AWM Investment Company, Inc. | 878,485 4.800% |
-193,347 (-18.04%) |
Filing History |
| 2024-11-14 3:18 pm Purchase |
2024-09-30 | 13G | OptimizeRx Corporation OPRX |
AWM Investment Company, Inc. | 1,071,832 5.900% |
1,071,832 (New Position) |
Filing History |
| 2024-11-14 11:25 am Sale |
2024-09-30 | 13G | OptimizeRx Corporation OPRX |
Divisadero Street Capital Management, LP | 3,118 0.020% |
-946,432 (-99.67%) |
Filing History |
| 2024-11-13 10:25 am Purchase |
2024-09-30 | 13G | OptimizeRx Corporation OPRX |
SAMJO MANAGEMENT, LLC | 1,044,800 5.700% |
1,044,800 (New Position) |
Filing History |
| 2024-06-10 09:00 am Purchase |
2024-05-31 | 13G | OptimizeRx Corporation OPRX |
First Light Asset Management, LLC | 1,829,074 10.010% |
100,644 (+5.82%) |
Filing History |
| 2024-02-14 5:05 pm Sale |
2023-12-31 | 13G | OptimizeRx Corporation OPRX |
First Light Asset Management, LLC | 1,728,430 9.520% |
-32,166 (-1.83%) |
Filing History |
| 2024-02-13 5:12 pm Sale |
2023-12-29 | 13G | OptimizeRx Corporation OPRX |
The Vanguard Group | 1,021,002 5.620% |
-90,409 (-8.13%) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
1,134,954 6.300% |
93,216 (+8.95%) |
Filing History |
| 2023-12-29 5:30 pm Purchase |
2023-12-22 | 13G | OptimizeRx Corporation OPRX |
Divisadero Street Capital Management, LP | 949,550 5.200% |
949,550 (New Position) |
Filing History |
| 2023-11-28 4:10 pm Purchase |
2023-10-24 | 13G | OptimizeRx Corporation OPRX |
Weintraub Michael | 1,384,467 7.600% |
1,384,467 (New Position) |
Filing History |
| 2023-06-09 4:31 pm Purchase |
2023-05-31 | 13G | OptimizeRx Corporation OPRX |
First Light Asset Management, LLC | 1,760,596 10.280% |
1,760,596 (New Position) |
Filing History |
| 2023-04-06 09:29 am Sale |
2023-03-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
1,041,738 6.100% |
-1,672,452 (-61.62%) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | OptimizeRx Corporation OPRX |
The Vanguard Group | 1,111,411 6.480% |
28,635 (+2.64%) |
Filing History |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | OptimizeRx Corporation OPRX |
BLACKROCK INC BLK |
2,714,190 15.800% |
46,102 (+1.73%) |
Filing History |
| 2022-02-11 3:42 pm Sale |
2021-12-31 | 13G | OptimizeRx Corporation OPRX |
BLAIR WILLIAM & CO | 730,674 4.100% |
-49,250 (-6.31%) |
Filing History |